Macrolide Antibiotics Market to Reach $7.0 Billion, globally, by 2032: Allied Market Research

The global macrolide antibiotics market is expanding rapidly due to factors such as a rise in incidences of bacterial infections, availability of generic medications and significant demand for macrolides from emerging countries. 

PORTLAND, Ore., Oct. 30, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Macrolide Antibiotics Market By Drug Type (Azithromycin, Erythromycin, Others), By Route Of Administration (Oral, Parenteral, Others), By Indication (Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers): Global Opportunity Analysis And Industry Forecast, 2023-2032″. The global macrolide antibiotics market was valued at $5.6 billion in 2022, and is projected to reach $7.0 billion by 2032, registering a CAGR of 2.3% from 2023 to 2032. 

Request Sample of the Report on Macrolide Antibiotics Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/70066 

Macrolides represent a class of antibiotics characterized by their macrocyclic lactone structure, to which one or more deoxy sugars are attached. These antibiotics function by irreversibly binding to a specific location on the 50S subunit of the bacterial ribosome, thereby inhibiting the translocation phase of protein synthesis. While they are typically considered bacteriostatic, at higher doses, they can exhibit bactericidal properties. Macrolide antibiotics are commonly prescribed for the treatment of various respiratory tract infections, including pneumonia, bronchitis, sinusitis, pharyngitis, as well as for managing sexually transmitted infections like chlamydia, gonorrhea, and others. 

Prime determinants of growth 

The global macrolide antibiotics market is expanding rapidly due to factors such as a rise in incidences of bacterial infections, availability of generic medications and significant demand for macrolides from emerging countries. However, a surge in antimicrobial resistance and side effects associated with macrolide antibiotics hinder the market growth to some extent. Nevertheless, rise in investments in research and development activities will provide ample growth opportunities in the upcoming future. 

Report coverage and details: 

 

Economic Downturn Analysis: Impact of Recession in 2023 on the Macrolide Antibiotics Market

Numerous sectors of the economy, particularly the pharmaceutical and biotechnology industries, have been impacted by the ongoing global recession. Antibiotic demand has fluctuated as laboratories and businesses shift their spending priorities as a result of reduced funding in industries including pharmaceuticals, biotechnology, and chemicals. 

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/70066 

The azithromycin segment to maintain its leadership status throughout the forecast period  

Based on drug type, the Azithromycin segment held the highest market share in 2022, accounting for nearly two-thirds of the global macrolide antibiotics market revenue and is projected to rule the roost throughout the forecast timeframe. The key drivers for the growth of azithromycin segment includes the widespread availability of azithromycin in both branded and generic forms. 

On the other hand, the others segment is anticipated to showcase the highest CAGR of 2.8% during the forecast period. This is attributed to the surge in incidences of bacterial infections around the globe, and effectives of macrolide antibiotics in treatment of severe bacterial infections. 

The oral segment to maintain its lead position during the forecast period 

Based on route of administration, the oral segment accounted for the largest share in 2022, accounting for nearly three-fourths of the global macrolide antibiotics market revenue and is anticipated to retain its dominance during the forecast period. The oral macrolide antibiotics segment is mainly boosted, owing to the availability of wide range of generic versions, which increases its adoption, and propels the market growth. The same segment would display the highest CAGR of 2.5% during the forecast period. 

The respiratory tract infections segment to maintain its lead position during the forecast period  

Based on indication, the respiratory tract infections segment accounted for the largest share in 2022, accounting for nearly two-fifths of the global macrolide antibiotics market revenue and is estimated to grab the lion’s share during the forecast period. Rise in prevalence of respiratory tract infections leads to increase in demand for macrolide antibiotics for its treatment, which propels the segment growth. The same segment is expected to manifest a notable CAGR of 2.8% from 2023 to 2032.   

The online providers segment to witness the fastest growth during the forecast period 

Based on distribution channel, the drug stores and retail pharmacies segment dominated the market in terms of revenue in 2022, accounting for more than half of the global market and is expected to maintain its dominance during the forecast period. This growth is attributed to the availability of a wide range of antibiotics to meet the needs of consumers. On the other hand, the online providers segment is anticipated to display the fastest CAGR of 3.1% during the forecast period, owing to numerous advantages such as quick accessibility and convenience. 

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/70066 

Asia-Pacific to maintain its dominance by 2032 

Based on region, Asia-Pacific held the highest market share of more than one-third of the global macrolide antibiotics market in 2022 and is projected to maintain its dominance during the forecast period. This is attributed to the large population base in countries such as China and India, rising healthcare expenditure, and developing healthcare infrastructure. The same region would display the fastest CAGR of 2.8% from 2023 to 2032. 

Leading Market Players: – 

Abbott Laboratories Pfizer Inc. Alkem Laboratories Ltd. Sun Pharmaceutical Industries Limited Teva Pharmaceutical Industries Limited Wellona Pharma Private Limited. Bristol Laboratories Ltd. Crescent Pharma Limited Merck And Co., Inc. Zydus Lifesciences Limited 

The report provides a detailed analysis of these key players in the global macrolide antibiotics market. These players have adopted different strategies such product approval and product launch to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario. 

 Comprehensive Healthcare Industry Research Studies:

Bone Grafts and Substitutes Market – Global Opportunity Analysis and Industry Forecast, 2022-2032

Companion Diagnostic Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

Infant Incubator Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Influenza Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Alopecia Treatment Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

Pneumonia Vaccine Market- Global Opportunity Analysis and Industry Forecast, 2022–2032

Empty Capsules Market – Global Opportunity Analysis and Industry Forecast, 2022–2032

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com  
Follow Us on: LinkedIn

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/macrolide-antibiotics-market-to-reach-7-0-billion-globally-by-2032-allied-market-research-301971402.html